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If  the  growth  rates  in  both  workers'  average  total  compensation  and  in employer‐sponsored health insurance premiums remain at their current rates, this share will increase to 15.0 percent by 2019 and will continue to increase thereafter (4). While the steadily increasing share of workers' total compensation taken up by health  insurance  premiums  illustrates  the  need  for  reform,  the  burden  it  places upon employers does as well. 
Health  care  costs  for  some  firms  can  have  a  crippling  effect  upon  their profitability. With double‐digit  increases  in health  care  spending,  some employers are  dissuaded  from hiring  new  full‐time,  benefit‐eligible  employees,  curtailing  the investment in human capital that firms need to make in order to grow. In particular, companies with a large pool of unionized retirees are especially hurt by rising costs as  they  are  forced  to  pass  on  this  burden  to  consumers  through  higher  prices.  A marked example of this is how the price tag for a General Motors vehicle consists of more health care than steel costs (5). With countries like Japan providing the bulk of its citizens’ health insurance, there is an obvious competitive advantage on the part of  foreign  firms.  Thus,  from  the  perspective  of  both  the  employee  and  employer, there  is  a palpable need  for health  insurance  reform  to  slow  this  growth  in  costs, increasing U.S.  firms’  competitiveness  and  allowing workers  to  enjoy  higher  take‐home wages.  
In addition to the impact health care related problems have on the American economy,  the  vast  number  of  uninsured  Americans  is  a  glaring  issue  in  need  of addressing  by  the  government.  According  to  the  Census  Bureau,  50.7  million 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Americans  lack  basic  health  insurance  (6).  While  it  may  seem  as  if  this  has  no consequence  for  the  rest of  the general population,  the  truth of  the matter  is  that insured  Americans  essentially  pay  to  cover  the  cost  of  the  uninsured.  Hospitals, particularly  in  inner  cities  and  rural  areas,  are  known  to  charge  patients  with insurance  higher  amounts,  in  order  to  cover  their  losses  incurred  by  uninsured patients who cannot pay their bills. This in turn raises insurance costs and feeds into the aforementioned problems associated with these higher costs. 
Beyond  the  simple  economics  behind  the  provision  of  health  care  through the insurance market, there is an inherent moral issue at hand in not allowing 50.7 million  Americans  to  have  access  to  the  medical  care  they  need  to  enjoy  a respectable quality of life (6). The concept of medical care as a fundamental right is not  novel  to  the  current  health  care  debate.  In  his  State  of  the  Union  Address  in 1944, President Roosevelt proposed an  “economic bill  of  rights”  that  included  the right  to  adequate  medical  care.  In  his  opinion,  the  first  bill  of  rights  “proved inadequate  to  assure  us  equality  in  the  pursuit  of  happiness”  (7).  A  year  later, President  Truman would  assert  in  a message  to  Congress  on November  19,  1945 that "The health of American children, like their education, should be recognized as a  definite  public  responsibility"  (8).  On  this  basis  he  proposed  a  controversial national health insurance plan that came to Congress in the form of a Social Security expansion  bill  popularly  known  as  the  W‐M‐D  bill  (8).  The  American  Medical Association  was  successful  in  defeating  the  bill  by  capitalizing  on  public  fears  of Communism  and  labeling  it  as  a  plan  for  “socialized  medicine”,  but  nevertheless 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President Truman was successful in the end at publicizing the issue of Health Care. 
The  Patient  Protection  and  Affordable  Care  Act  (H.R.  3590),  in  redressing these problems, has come to represent a  fundamental shift  in paradigm for United States  Health  Care.  Its  mandate  that  all  Americans  obtain  some  form  of  health insurance  by  2014  has  achieved  the  elusive  goal  of  extending  coverage  to  all Americans. With this achievement, debate over health care policy has been reframed around the question of what policy groundwork  is needed  in order  to extend care without  having  to  compromise  its  quality.  As  millions  more  Americans  enter  the insurance market,  unimpeded  by  any  denials  of  coverage  on  the  part  of  insurers, legislative measures to expand and educate the health care workforce, enhance care, and control costs are needed to prepare for this change. 
 
2. Workforce Expansion and Education    
a. Legislation   The  Patient  Protection  and  Affordable  Care  Act  (PPACA)  itself  contains  a number of  key provisions  that  aim  to  ameliorate problems  related  to  the massive influx of newly insured Americans and to make the U.S. health care system stronger in the long term. As outlined in Title V Health Care Workforce of PPACA, a variety of solutions have been proposed to  increase the U.S. health care workforce and build the human infrastructure to provide adequate care for all Americans. To assess the progress  in  this  area,  Title  V  mandates  the  creation  of  a  National  Healthcare Workforce  Commission  to  review  the  current  healthcare  workforce  supply  and distribution. As outlined in Section 5101, high priorities for the commission include: 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 (i)  Integrated health  care workforce planning  that  identifies health  care professional  skills  needed and maximizes the skill sets of health care professionals across disciplines.  (ii)  An  analysis  of  the  nature,  scopes  of  practice,  and  demands  for  health  care  workers  in  the enhanced information technology and management workplace.  (iii) An analysis of how to align Medicare and Medicaid graduate medical education policies with national workforce goals.  (iv)  The  education  and  training  capacity,  projected  demands,  and  integration with  the  health  care delivery system of each of the following:   (I) Nursing workforce capacity at all levels.   (II) Oral health care workforce capacity at all levels.   (III) Mental and behavioral health care workforce capacity at all levels.   (IV) Allied health and public health care workforce capacity at all levels. (V) Emergency medical service workforce capacity, including the retention and recruitment of the volunteer workforce, at all levels. (VI) The geographic distribution of health care providers as compared to the identified health care workforce needs of States and regions.   In addition to outlining in section 5102 the need for Federal grant money to be  allocated  to  reach  these  goals,  the  PPACA  provides  the  financial  incentives needed  to  encourage members  of  the workforce  to  obtain  the  training  needed  to fulfill these goals. Of special interest is the education loan and grant programs of the Public Health Service Act  (42 U.S.C. 294n et  seq.).  Sections 5203 and 5204 of H.R. 3590 amend Part E of title VII of the Public Health Service Act by adding to the end of it provisions that establish the following new loan repayment programs: 
 SEC. 775. INVESTMENT IN TOMORROW’S PEDIATRIC HEALTH CARE WORKFORCE. ESTABLISHMENT.—The  Secretary  shall  establish  and  carry  out  a  pediatric  specialty  loan  repayment program under which  the eligible  individual agrees  to be employed  full‐time  for a specified period (which shall not be less than 2 years) in providing pediatric medical subspecialty, pediatric surgical specialty,  or  child  and  adolescent  mental  and  behavioral  health  care,  including  substance  abuse prevention and treatment services.   SEC. 776. PUBLIC HEALTH WORKFORCE LOAN REPAYMENT PROGRAM. ESTABLISHMENT.—The Secretary shall establish the Public Health Workforce Loan Repayment Program (referred  to  in  this  section  as  the  ‘Program’)  to  assure  an  adequate  supply  of  public  health professionals to eliminate critical public health workforce shortages in Federal, State, local, and tribal public health agencies. 
 Section 5606, however, recognizes that while the aforementioned programs address the need to expand the health care workforce, they employ too broad of an approach to the problem. There are significant disparities in the provision of health 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care  throughout  the  nation with  rural  and  urban  areas  tending  to  be  particularly underserved. Therefore section 5606 appropriates money so that states may award grants  to  health  care  providers  who  treat  a  high  percentage  of  medically underserved populations or other special populations. Specifically, Part C of title VII of  the Public Health Service Act (42 U.S.C. 293k et seq.)  is amended so as  to assist “eligible  entities  in  recruiting  students  most  likely  to  practice  medicine  in underserved  rural  communities,  providing  rural‐focused  training  and  experience, and  increasing  the  number  of  recent  allopathic  and  osteopathic  medical  school graduates who practice in under‐served rural communities.”  
 
b. Improving Lower Science Education   The  PPACA  makes  tremendous  strides  in  improving  Higher  Education  in order  to  correct  for  shortages  in  the  health  care  workforce.  It  is  in  my  opinion, though, that Lower Education Science Programs must be improved in order for the aforementioned reforms to be successful. Higher education reform simply addresses a problem at too late of a stage in a student’s academic career. It is overly ambitious to  believe  that  implementing  student  loan  programs  or  increasing  advising  for students on  track  for a  career  in  the health care  field will  translate  into a marked expansion of that workforce. Students need a strong high school science curriculum in  order  to  feel  confident  enough  to  pursue  a  college  course  load  that  would adequately prepare  them  for advanced education  in a health‐related profession. A student matriculating  into an undergraduate  institution  from a high  school with a weak science curriculum will much more  likely be steered away from the sciences 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by one of the first or second year general science courses that are reputed to “weed out”  prospective  medical,  nursing,  or  pharmaceutical  students.  Had  that  same student  received  a  more  solid  science  education  throughout  high  school  that developed their analytical scientific skill set, there would be a far greater likelihood that they would successfully pursue a career in medicine.  
It is no secret that our nation’s lower science education programs are failing to  meet  expectations.  In  an  often‐cited  study  of  students  in  grades  4,  8,  and  12 throughout  the  U.S.  conducted  by  the  Nation’s  Report  Card,  a  congressionally authorized project of the National Center for Education Statistics (NCES) within the Institute  of  Education  Sciences  of  the  U.S.  Department  of  Education,  this  was painfully obvious (11).  In  this study,  the 2009 National Assessment of Educational Progress  (NAEP),  only  21  percent  of  twelfth‐graders  performed  at  or  above  the 
Proficient  level. Equally glaring of a statistic  is how a paltry 60 percent of  twelfth‐graders  performed  at  or  above  the  Basic  level  (11).  The  Basic  and  Proficient achievement  levels  describing  students’  performance  on  both multiple‐choice  and constructed‐response  questions  are  determined  by  the  NCES  Governing  Board based  on  recommendations  from  policymakers,  educators,  and  members  of  the general  public  (11). This  is  an  unacceptable  reality  if  America  is  to  remain competitive  in the future. A higher quality  lower education science program is not only an investment in the health care industry, but the broader economy as well. By investing  in  science  education,  we  are  cultivating  more  world‐class  engineers, inventors  and  researchers  as  well  as  doctors,  nurses,  physician  assistants,  and 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pharmacists.  
Beyond  the  simple  investments  in  lower  education  such  as  new  textbooks, lab equipment in schools, and teacher hires to improve student to teacher ratios, we need to  look at how we educate students  in the sciences. The current paradigm of science  education  is  to  distinguish  each  year  of  high  school  into  discrete  subjects reminiscent of a  layer cake with  life sciences being taught  freshman year  followed by biology,  chemistry,  and  lastly physics. A more  integrative approach  is  far more ideal for a couple of reasons. First, it allows educators to introduce topics and then revisit and build on the concept  later  in a student’s academic career. Covering key curricular material repeatedly ensures that students attain a much greater  lifelong understanding  of  science  that  will  translate  into  future  educational  endeavors. Otherwise  the  student needs only  to  retain  the  information  for  the  length of  time that they may be tested on it. Secondly, utilizing this integrative approach to science education,  students  have  a  greater  opportunity  to  develop  a  strong  analytical scientific  background  and  critical  thinking.  Drawing  inferences  across  scientific disciplines is essential in conducting and applying research to real life problems. By acquiring  this  proficiency  early  on,  students  are  honing  the  skills  to  make  them better scientists later in life.  
Creating a more integrative science curriculum is not novel. It first garnered national attention twenty years ago when the National Science Teachers Association published  their  Scope,  Sequence,  and  Coordination  Initiative  (12).  Its implementation has severely lagged behind its debate. Connecting the importance of 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lower science education reform to  the development and welfare of  the U.S. Health Care  workforce  is  the  best  way  for  policymakers  to  bring  about  real  educational reform.  In  addition  to  pursuing  a  more  integrative  curriculum,  high  achieving students  should  have  the  ability  to  engage  in  a  more  rigorous  educational environment. The most effective way of affording these students this experience is to  establish  magnet  science  academies  such  as  the  Greater  Hartford  Academy  of Math  and  Sciences  to  supplement  their  basic  curriculum.  Many  educators  would argue against this approach, as stated by Dr. Bonnie Brunkhorst, former President of the  National  Science  Teachers  Association,  “Mixing  does  not  require  that  our brightest  students  become  average  achievers.  Mixing  provides  opportunities  for interaction,  leadership,  and  success  in  science  for  all  students  at  the  level  that matches  their  capabilities”  (13).  However,  by  offering  higher  achieving  students additional opportunities to challenge themselves, they can be much more effectively driven  to  excel  further.  Not  only  does  a  magnet  program  offer  intellectual stimulation  through  a  more  rigorous  curriculum,  but  it  also  allows  students  to interact with a  larger pool of  students  from whom they can expand  their  learning through collaborative academic efforts. 
3. Primary Care & Preventative Medicine 
a. Legislation    Another key  component of  the PPACA  is  its  attempts  to  steer  the practice of medicine back towards primary care  in an effort  to bolster preventative medicine. Over  the  past  few  decades  there  has  been  a  shift  towards  specialized  care  in  the 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medical  field,  diminishing  the  role  of  primary  care.  However,  in  considering  the common  chronic  illnesses  that  affect  Americans  such  as  heart  disease,  type  2 diabetes,  cancer,  and  high  blood  pressure,  preventative  measures  directed  by  a primary physician are crucial  to a patient’s health and well being. Recognizing the ability  of  primary  care  to  increase  the  general  health  and  welfare  of  Americans, Section 5508 of  the Patient Protection and Affordable Care Act  increases  teaching capacity for primary care by amending Part C of title VII of the Public Health Service Act (42 U.S.C. 293k et seq.) by adding: 
 ‘‘SEC. 749A. TEACHING HEALTH CENTERS DEVELOPMENT GRANTS. ‘‘(a) PROGRAM AUTHORIZED.—The Secretary may award grants under this section to teaching health centers for the purpose of establishing new accredited or expanded primary care residency programs.  Furthermore, Section 5508 establishes a Primary Care Extension Program through amending  the  Public  Health  Service  Act  (42  U.S.C.  280g  et  seq.)  that  essentially enumerates  the  desire  to  promote  the  practice  of  preventative medicine  through primary care providers.   The Primary Care Extension Program shall provide support and assistance to primary care providers to  educate  providers  about  preventive  medicine,  health  promotion,  chronic  disease  management, mental  and  behavioral  health  services  (including  substance  abuse  prevention  and  treatment services),  and evidence‐based and evidence‐informed  therapies  and  techniques,  in order  to  enable providers  to  incorporate  such  matters  into  their  practice  and  to  improve  community  health  by working with community‐based health connectors (referred to in this section as ‘Health Extension Agents’).  
b. Utilizing Education to Promote Primary Care 
 The  United  States medical  education  system  has  already  begun  to  address the  critical  health  care  need  for  more  primary  care  provision.  Of  special  note  is Quinnipiac  University’s  decision  to  establish  its  own  medical  school  with  an 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a. Legislation   The  PPACA  recognizes  that  rising  prescription  drug  costs  are  one  of  the leading  causes  of  runaway  health  care  costs.  The  Act  attempts  to  address  this concern for the  long‐term health of Medicare by amending Title XVIII of the Social Security Act (42 U.S.C. 1395 et seq.) to establish an ‘Independent Medicare Advisory Board’. This body is charged with the task of recommending ways to reduce the per capita rate of growth in Medicare spending to Congress.  
As  appropriate,  the  proposal  shall  include  recommendations  to  reduce Medicare  payments  under parts C and D, such as reductions in direct subsidy payments to Medicare Advantage and prescription drug  plans  specified  under  paragraph  (1)  and  (2)  of  section  1860D–15(a)  that  are  related  to administrative expenses  (including profits)  for basic coverage, denying high bids or removing high bids for prescription drug coverage from the calculation of the national average monthly bid amount under  section  1860D–13(a)(4),  and  reductions  in  payments  to  Medicare  Advantage  plans  under clauses  (i)  and  (ii)  of  section 1853(a)(1)(B)  that  are  related  to  administrative  expenses  (including profits) and performance bonuses for Medicare Advantage plans under section 1853(n).   
Any  such  recommendation  shall  not  affect  the  base  beneficiary  premium percentage  specified under 1860D–13(a). As Medicare pays  roughly 30 percent of the  nation’s  retail  drug  bills,  a  recommendation  to  remove  a  high  bid  from  the calculation  of  the  national  average  monthly  bid  amount  can  have  an  enormous impact (21). 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b. Sustained Pharmaceutical Innovation   Beyond the need to control the increase in prescription drug costs in order to avoid  the  bankruptcy  of  Medicare  and  Medicaid,  there  are  other  pertinent pharmaceutical  concerns  looming  over  the  U.S.  health  care  industry.  Americans’ spending on prescriptions per capita is higher than any other nation. This has been pointed  to  as  a  source  of waste  and mismanagement  in  our  health  care  industry, while  at  the  same  time  it  has  also  fueled  the  pharmaceutical  industry’s  research engine. This  trend  is  likely  to reverse as patents on a number of  “megamedicines” whose annual sales have neared $50 billion expire in the next few years (10). This year, 2011, has been referred to as the “patent cliff” as a number of medicines that are  integral  to  drug  companies’  profitabilities will  have  their  patents  expire  (10). For example, Pfizer Inc.  is set to lose control of Lipitor and Xalatan, two of  its best selling drugs. Lipitor alone accounts for more than $12.4 billion of Pfizer’s current annual revenue, yet it must legally allow Ranbaxy Laboratories Ltd. of India to sell generic  versions  of  the  drug  in  the United  States starting November  30,  2011 (9). This  year GlaxoSmithKline Plc. will  also  lose  the patent  to Advair  this  year, which alone accounts for 18% of its sales (9). 
Most pharmaceutical companies  lack new blockbuster drugs to compensate for the loss in revenue from patent expirations, and so it  is expected that research and development budgets will be slashed across the industry. Seventy‐five percent of prescriptions  in  the United States are already now low‐price,  low‐profit generic drugs,  so  this  new wave of  key patent  expirations  is  truly  a  crippling blow  to  the 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industry (10). Of course, in the short term, this is beneficial to consumers as it stems the pattern of rising Medicare costs. However, if firms fail to produce new drugs to meet the public’s need, the long‐term social costs are quite substantial. The primary concern  is  that  a  reduction  in  research  and  development  spending  amongst pharmaceutical companies will evolve into a vicious cycle in which such reductions prevent future drug discovery and feedback into greater budget cuts. Dr. Francis S. Collins, director of the National Institutes of Health (NIH), realizes that “We seem to have  a  systemic  problem  here,”  and  has  thus  proposed  a  billion‐dollar  drug development  center  at  the  National  Institute  of  Health  (10).  Pharmaceutical innovation  has  long  been  a  hallmark  of  our  current  health  care  system’s  success. Moving  forward,  it  is  critical  that  the  government  is  equipped  to  pair  with  the private sector in order to ensure that this endures.  
It  is  in  the  public’s  best  interest  for  our  pharmaceutical  sector  to  remain capable of meeting the need for new treatment options. For example, the number of multi‐drug resistant bacterial strains is a serious problem that would greatly benefit from the coupling of basic research and pharmaceutical innovation. This can only be accomplished  by  giving  credence  to  Dr.  Collin’s  proposal,  which  includes appropriating  National  Institute  of  Health  funds  for  targeted  drug  development endeavors  involving  both  academia  and  the  private  sector.  Currently  the  agency supports  clinical  and  translational  research  that  transforms  discoveries  from untargeted research into medical practice. The National Institute of Health has had success  in  this  capacity,  notably  the  development  of  a  vaccine  for  cervical  cancer, underscoring their effectiveness in drug discovery. If they were to make a concerted 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effort to collaborate with the private sector, I am confident this partnership would allow for continued pharmaceutical innovation.  
Tightening budgets throughout the public sector including the NIH due to the weak U.S.  economy  further  complicates  this  situation.  This makes  the  question  of whether to divert funding away from basic research, which does essentially provide the framework for all drug discoveries, towards strictly translational research more difficult. Nevertheless, additional resources to enhance small business development would  certainly  be  an  ideal  solution.  A  business  accelerator  would  allow  smaller NIH funded labs to continue to conduct basic research and maintain control of their proprietary information while providing the business and scientific wherewithal to effectively turn it into a commercially viable product that serves a public good.  
5. Tort Reform   The issue of Medical Malpractice Tort Reform must be seriously addressed if we are to curb the dramatic growth in medical expenditures. Large legal settlements due  to malpractice  lawsuits  inflate  the  cost  of  basic medical  expenses  as  doctors raise  prices  to  cover  their  insurance  costs.  Furthermore,  the  fear  of  facing  a financially  crippling  malpractice  suit  has  led  most  doctors  to  practice  “defensive medicine”. From a cost perspective this has the negative effect of leading doctors to order  what  is  in  many  cases  an  unnecessary  number  of  tests  prior  to  surgery. According to a 2003 study conducted by the U.S. Department of Health and Human Services, defensive medical practices account for somewhere between 5 and 9% of total  U.S.  health  care  expenditures  (14).  Medically  speaking,  defensive  medical 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practices can even reduce the quality of care a patient may receive as doctors may steer patients  away  from  riskier procedures  that may be  exactly what  the patient needs.  
Section 10607 of the Patient Protection and Affordable Care Act amends the Public Health Service Act  (42 U.S.C. 280g et  seq.)  to establish  state demonstration programs  to  evaluate  alternatives  to  current  medical  tort  litigation.  However,  it contains no binding legislation to actually bring about meaningful change. To some, this lack of binding reform is welcome, as they perceive tort reform as a red herring in  the  health  care  debate.  They  often  cite  how  medical  malpractice  payments comprise  only  two  percent  of  total  health  care  spending  according  to  both  the United  States  Department  of  Health  and  Human  Services  and  the  Congressional Budget  Office  (17,  18).  Furthermore,  in  considering  the  annual  number  of  paid medical malpractice claims according to the National Practitioner Data Bank (NPDB) and  Physician  Insurers  Association  of  America  (PIAA),  we  see  only  a  modest increase in claims over time. 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Figure 3. Growth  in number of paid medical malpractice  claims. This  figure was  adapted  from  the Kaiser Family  report  on “Medical Malpractice Law in the United States” Author calculations use data from the National Practitioner Data Bank (NPDB) and the Physicians Insurers Association of America (PIAA) (19).   Figure  3  shows  the  number  of  medical  malpractice  claims  each  year  from 1991  to  2003  according  to  the  NPDB  data  and  from  1994‐2002  according  to  the PIAA data. In considering just the start and end points in order to show a long‐term trend,  the  NPDB  data  indicates  a  12%  increase while  the  PIAA  data  shows  a  7% increase (19). 
In  using  this  data  to  substantiate  claims  that medical malpractice  lawsuits are  not  a  growing  concern  for  the  health  of  the  industry,  a  number  of  important points  are  being  overlooked.  The  first  is  the  dramatic  rise  in  the  average  defense cost per claim. 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Figure 4. Growth  in average malpractice defense costs per claim. This  figure was adapted  from the Kaiser Family report on “Medical Malpractice Law in the United States” Author calculations use data from the National Practitioner Data Bank (NPDB) and the Physicians Insurers Association of America (PIAA) and adjusted for inflation using the Bureau of Labor Statistics Consumer Price Index (19).   Figure 4 illustrates that within a ten‐year period of time, the average cost of all claims has doubled. This far outpaces the rate of inflation over the course of that period. Therefore, while the number of claims has not risen substantially, the costs of each claim have, which does not bode well for the medical malpractice insurance industry. Of special note  in considering the rising cost of claims  is how the cost of “no payment claims” has nearly doubled from 1991 to 2001, rising from $12,000 to $23,500 (19). 






















disparity, the NPDB reports that payments ranged as low as $121,313 for the state of Michigan to a high of $483,319 for the state of Connecticut (19). In states where payments are high, the resulting increase in insurance premiums will prompt some physicians to reduce high‐risk services or  in other more extreme circumstances to move or even close practices. This translates into a deficiency of care in these areas. One of the fundamental tenets of the Patient Protection and Affordable Care Act is to allow  all  Americans  easy  access  to  high  quality,  affordable  care.  This  cannot  be achieved if the high cost of medical malpractice insurance in one part of the country forces doctors in that area to reduce their offering of certain services deemed to be high risk in terms of potential litigation, such as mammograms, newborn deliveries, and spinal surgeries.   
The  U.S.  General  Accounting  Office  asserts  that  “Cycles  in  the  medical malpractice  market  tend  to  be  more  extreme  than  in  other  insurance  markets because of the longer period of time required to resolve medical malpractice claims, and  factors  such  as  changes  in  investment  income  and  reduced  competition  can exacerbate the fluctuations.” (20) At the same time, the medical malpractice market has  a  marked  influence  upon  the  broader  health  care  industry.  It  would  be  my recommendation that legislation be passed to cap the amount of money awarded for “pain  and  suffering”,  which  often  bloats  settlement  figures,  while  allowing  for unlimited  “actual”  damages  for  injuries.  Such  a  solution  would  allow  one  to medically become whole again, while acknowledging their pain and suffering within reason.  Data  shows  that  such  a  cap  can  help  stabilize  the  medical  malpractice 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market.  “For  example,  from  2001  through  2002  average  premium  rates  rose approximately  10  percent  in  the  four  states  with  noneconomic  damage  caps  of $250,000 but approximately 29 percent  in  states with more  limited  tort  reforms.” (20) Without  tort  reform distortions  in  the health  care workforce will persist  and most likely become more pronounced into the future. While health care reform is a top  down  effort,  it  must  be  often  analyzed  from  a  grass  roots  level.  Allowing  for Americans  to  not  have  access  to  certain  procedures  due  problems  in  the medical malpractice market represents not only a failure in the efforts of the ongoing reform effort, but also a violation of their right to health care.  
 
6. Conclusion 
In  many  ways,  health  care  reform  can  be  aptly  described  as  throwing spaghetti at a wall to see what sticks. It is impossible to say with absolute certainty what  specific  reforms will  turn  around  our  deeply  troubled  health  care  industry. Nevertheless, this is an onerous task that must be undertaken for our nation’s health as a whole. It is more than fair to say that health care is perhaps the greatest threat to America’s future success. Not only does the private sector depend on the success of health care reform, but the public sector does as well. In addressing issues such as the  ever‐expanding  federal  budget,  the  role  health  care  costs  play  in  rising entitlement  spending  is  integral  to  any  serious debate. The positive  aspect  to  this situation is that we are truly faced with a long‐term health care problem. Therefore, we  are  afforded  the  ability  to  treat  it  as  thus.  In  the  Patient  Protection  and 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Affordable Care Act, the ability to review the progress of specific reforms and fine‐tune them down the road has been provided for. Of course, assessing the progress of various  reforms  presents  a  whole  host  of  other  challenges.  Each  reform  will inherently take a different amount of time to have an effect. For example, while the impact of the individual mandate for health insurance will be discretely felt in 2014 as  it  comes  into  place,  legislation  supporting  primary  care  and  preventative medicine will have a much more long‐term effect. Nevertheless, challenges involving the assessment of reform falls  in line with how the Act acknowledges that it  is not meant to be a comprehensive final solution to the problems with the U.S. health care system,  but  rather  the  first  step  of  many.  The  solutions  this  paper  enumerates, partnership with the pharmaceutical industry, lower science education reform, and tort reform, simply represent three of many potential next steps to come in moving U.S. Health Care forward. 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